NEW YORK (Reuters Health) - More babies born via cesarean section grow up to be heavy kids and teens than those delivered vaginally, according to a new study of more than 10,000 UK infants.
Eleven-year-olds delivered ...
NEW YORK (Reuters) - A long-awaited report on workplace wellness programs, which has still not been publicly released, delivers a blow to the increasingly popular efforts, Reuters has learned, casting doubt on a pillar ...
NEW YORK (Reuters Health) - Back pain, migraine and other types of chronic pain without a known physical cause - and therefore little prospect for relief - were associated with an increased risk of suicide in a new ...
NEW YORK (Reuters Health) - Despite expert guidelines advising against intense sports activity for people with implanted heart defibrillators, a new study suggests that some can compete without serious ...
(Reuters) - The Food and Drug Administration said on Friday it has received seven reports of illnesses in patients who took steroid injections compounded by a pharmacy in Tennessee.
The FDA said full clinical ...
GENEVA (Reuters) - The World Health Organization (WHO) said on Friday that it would help Saudi Arabia dig deeper into deadly outbreaks of a new SARS-like virus to draw up advice ahead of the annual haj pilgrimage, ...
HONG KONG (Reuters) - The new H7N9 bird flu virus can be transmitted between mammals not only via direct contact but also in airborne droplets, and may be capable of spreading from person to person, Chinese and ...
NEW YORK (Reuters) - Canada's Valeant Pharmaceuticals International is nearing a deal to acquire eye care company Bausch & Lomb Holdings Inc from Warburg Pincus LLC for about $9 billion, a person familiar with the ...
WASHINGTON (Reuters) - Representative Edward Markey, a Democrat from Massachusetts, on Thursday became the latest lawmaker to propose legislation that would give the U.S. Food and Drug Administration greater regulatory ...
NEW BRUNSWICK, New Jersey (Reuters) - Johnson & Johnson said it plans to seek approvals for 11 new drugs by 2017, including a treatment for patients with depression who have failed to benefit from standard ...
